Cannassure Therapeutics (Israel) Buy Hold or Sell Recommendation
| CSURE Stock | 717.00 62.80 8.05% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Cannassure Therapeutics is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Cannassure Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Cannassure Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cannassure Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Cannassure and provide practical buy, sell, or hold advice based on investors' constraints. Cannassure Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Cannassure |
Execute Cannassure Therapeutics Buy or Sell Advice
The Cannassure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cannassure Therapeutics. Macroaxis does not own or have any residual interests in Cannassure Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cannassure Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cannassure Therapeutics Trading Alerts and Improvement Suggestions
| Cannassure Therapeutics generated a negative expected return over the last 90 days | |
| Cannassure Therapeutics has high historical volatility and very poor performance | |
| The company reported the revenue of 16.32 M. Net Loss for the year was (28.54 M) with loss before overhead, payroll, taxes, and interest of (14.17 M). | |
| Cannassure Therapeutics generates negative cash flow from operations | |
| About 51.0% of the company shares are held by company insiders |
Cannassure Therapeutics Returns Distribution Density
The distribution of Cannassure Therapeutics' historical returns is an attempt to chart the uncertainty of Cannassure Therapeutics' future price movements. The chart of the probability distribution of Cannassure Therapeutics daily returns describes the distribution of returns around its average expected value. We use Cannassure Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cannassure Therapeutics returns is essential to provide solid investment advice for Cannassure Therapeutics.
| Mean Return | -0.2 | Value At Risk | -11.77 | Potential Upside | 10.00 | Standard Deviation | 6.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cannassure Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cannassure Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cannassure Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cannassure Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cannassure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | -0.19 | |
σ | Overall volatility | 6.00 | |
Ir | Information ratio | -0.02 |
Cannassure Therapeutics Volatility Alert
Cannassure Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cannassure Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cannassure Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cannassure Therapeutics Fundamentals Vs Peers
Comparing Cannassure Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cannassure Therapeutics' direct or indirect competition across all of the common fundamentals between Cannassure Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cannassure Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cannassure Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cannassure Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cannassure Therapeutics to competition |
| Fundamentals | Cannassure Therapeutics | Peer Average |
| Return On Equity | -2.11 | -0.31 |
| Return On Asset | -0.52 | -0.14 |
| Profit Margin | (1.53) % | (1.27) % |
| Operating Margin | (1.52) % | (5.51) % |
| Current Valuation | 56.54 M | 16.62 B |
| Shares Outstanding | 51.17 M | 571.82 M |
| Shares Owned By Insiders | 51.49 % | 10.09 % |
| Shares Owned By Institutions | 1.00 % | 39.21 % |
| Price To Sales | 0.05 X | 11.42 X |
| Revenue | 16.32 M | 9.43 B |
| Gross Profit | (14.17 M) | 27.38 B |
| EBITDA | (20.64 M) | 3.9 B |
| Net Income | (28.54 M) | 570.98 M |
| Book Value Per Share | 0.14 X | 1.93 K |
| Cash Flow From Operations | (20.82 M) | 971.22 M |
| Earnings Per Share | (0.31) X | 3.12 X |
| Number Of Employees | 44 | 18.84 K |
| Beta | 0.69 | -0.15 |
| Market Capitalization | 384.26 K | 19.03 B |
Cannassure Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cannassure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cannassure Therapeutics Buy or Sell Advice
When is the right time to buy or sell Cannassure Therapeutics? Buying financial instruments such as Cannassure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cannassure Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.